Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphopyruvate hydratase activity	ENO1 ENO2 ENO3	2.24e-06	4	166	3	GO:0004634
GeneOntologyMolecularFunction	carbon-oxygen lyase activity	NEIL1 ACO1 POLG IREB2 ENO1 ENO2 ENO3	5.44e-06	82	166	7	GO:0016835
GeneOntologyMolecularFunction	hydro-lyase activity	ACO1 IREB2 ENO1 ENO2 ENO3	1.78e-04	63	166	5	GO:0016836
GeneOntologyMolecularFunction	glycosylceramide flippase activity	ATP10B ATP10D	2.05e-04	3	166	2	GO:0140351
GeneOntologyMolecularFunction	iron-responsive element binding	ACO1 IREB2	2.05e-04	3	166	2	GO:0030350
GeneOntologyMolecularFunction	heparan sulfate 6-O-sulfotransferase activity	HS6ST1 HS6ST3	2.05e-04	3	166	2	GO:0017095
GeneOntologyMolecularFunction	aconitate hydratase activity	ACO1 IREB2	2.05e-04	3	166	2	GO:0003994
GeneOntologyMolecularFunction	serine-type peptidase activity	PRTN3 RBP3 CPD GZMA GZMM PRSS50 CELA1 KLK9	3.47e-04	207	166	8	GO:0008236
GeneOntologyMolecularFunction	serine hydrolase activity	PRTN3 RBP3 CPD GZMA GZMM PRSS50 CELA1 KLK9	4.07e-04	212	166	8	GO:0017171
GeneOntologyMolecularFunction	lyase activity	GAD1 NEIL1 ACO1 POLG IREB2 ENO1 ENO2 ENO3	4.07e-04	212	166	8	GO:0016829
GeneOntologyMolecularFunction	hexose-phosphate:phosphate antiporter activity	SLC37A1 SLC37A2	4.08e-04	4	166	2	GO:0015526
GeneOntologyMolecularFunction	hexose phosphate transmembrane transporter activity	SLC37A1 SLC37A2	4.08e-04	4	166	2	GO:0015119
GeneOntologyMolecularFunction	glucose-6-phosphate transmembrane transporter activity	SLC37A1 SLC37A2	4.08e-04	4	166	2	GO:0015152
GeneOntologyMolecularFunction	glucose 6-phosphate:phosphate antiporter activity	SLC37A1 SLC37A2	4.08e-04	4	166	2	GO:0061513
GeneOntologyMolecularFunction	ferroxidase activity	HEPH HEPHL1	1.01e-03	6	166	2	GO:0004322
GeneOntologyMolecularFunction	oxidoreductase activity, acting on metal ions, oxygen as acceptor	HEPH HEPHL1	1.01e-03	6	166	2	GO:0016724
GeneOntologyMolecularFunction	peptidase activity	PRTN3 ADAM23 RBP3 ADAM30 CPD OTUD7B GZMA GZMM OTUD7A ADAMTS16 ADAMTS17 PRSS50 CELA1 KLK9	1.16e-03	654	166	14	GO:0008233
GeneOntologyMolecularFunction	organophosphate:phosphate antiporter activity	SLC37A1 SLC37A2	1.40e-03	7	166	2	GO:0015315
GeneOntologyCellularComponent	phosphopyruvate hydratase complex	ENO1 ENO2 ENO3	1.92e-06	4	165	3	GO:0000015
Domain	-	NWD1 EML6 FSTL4 NUP43 SPAG9 WDR76 BIRC6 WDFY2 DMXL1 WDR74 FZR1 EML5 ARHGEF10 NUP37 NBEAL2 WDR90 NSMAF FBXW7	1.06e-09	333	166	18	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	NWD1 EML6 FSTL4 NUP43 SPAG9 WDR76 BIRC6 WDFY2 DMXL1 WDR74 FZR1 EML5 ARHGEF10 NUP37 NBEAL2 WDR90 NSMAF FBXW7	1.17e-09	335	166	18	IPR015943
Domain	WD40_repeat_dom	NWD1 EML6 NUP43 SPAG9 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 ARHGEF10 NUP37 NBEAL2 WDR90 NSMAF FBXW7	9.88e-09	297	166	16	IPR017986
Domain	WD40	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	8.28e-08	259	166	14	PF00400
Domain	WD40	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	1.26e-07	268	166	14	SM00320
Domain	WD40_repeat	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	1.51e-07	272	166	14	IPR001680
Domain	WD_REPEATS_1	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	1.98e-07	278	166	14	PS00678
Domain	WD_REPEATS_2	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	2.06e-07	279	166	14	PS50082
Domain	WD_REPEATS_REGION	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	2.06e-07	279	166	14	PS50294
Domain	Enolase_N	ENO1 ENO2 ENO3	6.90e-07	3	166	3	PF03952
Domain	Enolase	ENO1 ENO2 ENO3	6.90e-07	3	166	3	IPR000941
Domain	Enolase_C	ENO1 ENO2 ENO3	6.90e-07	3	166	3	IPR020810
Domain	Enolase_N	ENO1 ENO2 ENO3	6.90e-07	3	166	3	IPR020811
Domain	Enolase_CS	ENO1 ENO2 ENO3	6.90e-07	3	166	3	IPR020809
Domain	Enolase_C	ENO1 ENO2 ENO3	6.90e-07	3	166	3	PF00113
Domain	Enolase_N	ENO1 ENO2 ENO3	6.90e-07	3	166	3	SM01193
Domain	Enolase_C	ENO1 ENO2 ENO3	6.90e-07	3	166	3	SM01192
Domain	ENOLASE	ENO1 ENO2 ENO3	6.90e-07	3	166	3	PS00164
Domain	-	ENO1 ENO2 ENO3	2.74e-06	4	166	3	3.30.390.10
Domain	-	ENO1 ENO2 ENO3	2.74e-06	4	166	3	3.20.20.120
Domain	Enolase_C-like	ENO1 ENO2 ENO3	2.74e-06	4	166	3	IPR029065
Domain	Enolase_N-like	ENO1 ENO2 ENO3	2.74e-06	4	166	3	IPR029017
Domain	WD40_repeat_CS	NWD1 EML6 NUP43 WDFY2 FZR1 EML5 NUP37 WDR90 FBXW7	1.63e-05	164	166	9	IPR019775
Domain	Apc4_WD40_dom	NWD1 EML6 FZR1 EML5	2.61e-05	20	166	4	IPR024977
Domain	ANAPC4_WD40	NWD1 EML6 FZR1 EML5	2.61e-05	20	166	4	PF12894
Domain	Cezanne-2	OTUD7B OTUD7A	7.85e-05	2	166	2	IPR033477
Domain	Aconitase/IRP2	ACO1 IREB2	7.85e-05	2	166	2	IPR006249
Domain	AconitaseA/IPMdHydase_ssu_swvl	ACO1 IREB2	2.34e-04	3	166	2	IPR000573
Domain	Aconitase_C	ACO1 IREB2	2.34e-04	3	166	2	PF00694
Domain	-	ACO1 IREB2	2.34e-04	3	166	2	3.30.499.10
Domain	MULTICOPPER_OXIDASE2	HEPH HEPHL1	2.34e-04	3	166	2	PS00080
Domain	Acoase/IPM_deHydtase_lsu_aba	ACO1 IREB2	2.34e-04	3	166	2	IPR001030
Domain	-	ACO1 IREB2	2.34e-04	3	166	2	3.40.1060.10
Domain	-	ACO1 IREB2	2.34e-04	3	166	2	3.20.19.10
Domain	Acoase/IPM_deHydtase	ACO1 IREB2	2.34e-04	3	166	2	IPR015937
Domain	Acnase/IPM_dHydase_lsu_aba_1/3	ACO1 IREB2	2.34e-04	3	166	2	IPR015931
Domain	Aconitase/IPMdHydase_lsu_aba_2	ACO1 IREB2	2.34e-04	3	166	2	IPR015932
Domain	ACONITASE_1	ACO1 IREB2	2.34e-04	3	166	2	PS00450
Domain	Aconitase/3IPM_dehydase_swvl	ACO1 IREB2	2.34e-04	3	166	2	IPR015928
Domain	Aconitase	ACO1 IREB2	2.34e-04	3	166	2	PF00330
Domain	Aconitase_4Fe-4S_BS	ACO1 IREB2	2.34e-04	3	166	2	IPR018136
Domain	Heparan_SO4-6-sulfoTrfase	HS6ST1 HS6ST3	2.34e-04	3	166	2	IPR010635
Domain	ACONITASE_2	ACO1 IREB2	2.34e-04	3	166	2	PS01244
Domain	Pep_M12B_propep	ADAM23 ADAM30 ADAMTS16 ADAMTS17	3.88e-04	39	166	4	PF01562
Domain	Peptidase_M12B_N	ADAM23 ADAM30 ADAMTS16 ADAMTS17	3.88e-04	39	166	4	IPR002870
Domain	DISINTEGRIN_1	ADAM23 ADAM30 ADAMTS16 ADAMTS17	4.29e-04	40	166	4	PS00427
Domain	Reprolysin	ADAM23 ADAM30 ADAMTS16 ADAMTS17	4.29e-04	40	166	4	PF01421
Domain	ADAM_MEPRO	ADAM23 ADAM30 ADAMTS16 ADAMTS17	4.29e-04	40	166	4	PS50215
Domain	DISINTEGRIN_2	ADAM23 ADAM30 ADAMTS16 ADAMTS17	4.29e-04	40	166	4	PS50214
Domain	Peptidase_M12B	ADAM23 ADAM30 ADAMTS16 ADAMTS17	4.29e-04	40	166	4	IPR001590
Domain	Cu-oxidase_2	HEPH HEPHL1	4.66e-04	4	166	2	IPR011706
Domain	Sugar_P_transporter	SLC37A1 SLC37A2	4.66e-04	4	166	2	IPR000849
Domain	Cu-oxidase_2	HEPH HEPHL1	4.66e-04	4	166	2	PF07731
Domain	Disintegrin_dom	ADAM23 ADAM30 ADAMTS16 ADAMTS17	4.72e-04	41	166	4	IPR001762
Domain	Peptidase_S1A	PRTN3 GZMA GZMM PRSS50 CELA1 KLK9	5.19e-04	113	166	6	IPR001314
Domain	TRYPSIN_DOM	PRTN3 GZMA GZMM PRSS50 CELA1 KLK9	5.70e-04	115	166	6	PS50240
Domain	Tryp_SPc	PRTN3 GZMA GZMM PRSS50 CELA1 KLK9	6.25e-04	117	166	6	SM00020
Domain	Trypsin_dom	PRTN3 GZMA GZMM PRSS50 CELA1 KLK9	7.45e-04	121	166	6	IPR001254
Domain	Trypsin	PRTN3 GZMA GZMM PRSS50 CELA1 KLK9	7.45e-04	121	166	6	PF00089
Domain	Cu-oxidase_3	HEPH HEPHL1	7.72e-04	5	166	2	IPR011707
Domain	MULTICOPPER_OXIDASE1	HEPH HEPHL1	7.72e-04	5	166	2	PS00079
Domain	Cu_oxidase_CS	HEPH HEPHL1	7.72e-04	5	166	2	IPR033138
Domain	Cu-oxidase_3	HEPH HEPHL1	7.72e-04	5	166	2	PF07732
Domain	Peptidase_S1_PA	PRTN3 GZMA GZMM PRSS50 CELA1 KLK9	8.12e-04	123	166	6	IPR009003
Domain	GAR	GAS2L3 GAS2L1	1.15e-03	6	166	2	PS51460
Domain	HELP	EML6 EML5	1.15e-03	6	166	2	PF03451
Domain	Cu_oxidase_Cu_BS	HEPH HEPHL1	1.15e-03	6	166	2	IPR002355
Domain	GAS2	GAS2L3 GAS2L1	1.15e-03	6	166	2	PF02187
Domain	-	GAS2L3 GAS2L1	1.15e-03	6	166	2	3.30.920.20
Domain	HELP	EML6 EML5	1.15e-03	6	166	2	IPR005108
Domain	GAS_dom	GAS2L3 GAS2L1	1.15e-03	6	166	2	IPR003108
Domain	GAS2	GAS2L3 GAS2L1	1.15e-03	6	166	2	SM00243
Domain	TRYPSIN_SER	PRTN3 GZMA GZMM CELA1 KLK9	1.25e-03	90	166	5	IPR033116
Domain	Quinoprotein_ADH-like_supfam	NWD1 EML6 EML5 WDR90	1.26e-03	53	166	4	IPR011047
Domain	ZF_A20	OTUD7B OTUD7A	1.60e-03	7	166	2	PS51036
Domain	zf-A20	OTUD7B OTUD7A	1.60e-03	7	166	2	PF01754
Domain	Znf_A20	OTUD7B OTUD7A	1.60e-03	7	166	2	IPR002653
Domain	ZnF_A20	OTUD7B OTUD7A	1.60e-03	7	166	2	SM00259
Domain	ADAM_Cys-rich	ADAM23 ADAM30 ADAMTS17	1.72e-03	27	166	3	IPR006586
Domain	ACR	ADAM23 ADAM30 ADAMTS17	1.72e-03	27	166	3	SM00608
Domain	Gal_Oxase/kelch_b-propeller	IPP MEGF8 KLHL36 KLHL4	1.87e-03	59	166	4	IPR011043
Domain	PH-BEACH_dom	NBEAL2 NSMAF	2.12e-03	8	166	2	IPR023362
Domain	-	NBEAL2 NSMAF	2.12e-03	8	166	2	2.30.29.40
Domain	Epox_hydrolase-like	EPHX2 EPHX4	2.12e-03	8	166	2	IPR000639
Domain	PH_BEACH	NBEAL2 NSMAF	2.12e-03	8	166	2	PS51783
Domain	TRYPSIN_HIS	PRTN3 GZMA GZMM CELA1 KLK9	2.27e-03	103	166	5	IPR018114
Domain	-	EPHX2 ATP10B EYA2 ATP10D	2.53e-03	64	166	4	3.40.50.1000
Domain	ZF_DAG_PE_1	DGKG PRKCH PRKD1 PLEKHM3	2.53e-03	64	166	4	PS00479
Domain	ZF_DAG_PE_2	DGKG PRKCH PRKD1 PLEKHM3	2.53e-03	64	166	4	PS50081
Domain	TRYPSIN_SER	PRTN3 GZMA GZMM CELA1 KLK9	2.57e-03	106	166	5	PS00135
Domain	C1	DGKG PRKCH PRKD1 PLEKHM3	2.67e-03	65	166	4	SM00109
Domain	TRYPSIN_HIS	PRTN3 GZMA GZMM CELA1 KLK9	2.68e-03	107	166	5	PS00134
Domain	BEACH	NBEAL2 NSMAF	2.71e-03	9	166	2	PS50197
Domain	Beach	NBEAL2 NSMAF	2.71e-03	9	166	2	PF02138
Domain	-	NBEAL2 NSMAF	2.71e-03	9	166	2	1.10.1540.10
Domain	Beach	NBEAL2 NSMAF	2.71e-03	9	166	2	SM01026
Domain	BEACH_dom	NBEAL2 NSMAF	2.71e-03	9	166	2	IPR000409
Domain	PE/DAG-bd	DGKG PRKCH PRKD1 PLEKHM3	2.83e-03	66	166	4	IPR002219
Domain	Gal_Oxidase_b-propeller	IPP KLHL36 KLHL4	3.37e-03	34	166	3	IPR015916
Domain	Rap_GAP	RALGAPA1 RALGAPA2	3.37e-03	10	166	2	PF02145
Pathway	REACTOME_GLUCONEOGENESIS	SLC37A1 SLC37A2 ENO1 ENO2 ENO3	2.87e-06	26	125	5	M13748
Pathway	REACTOME_GLUCOSE_METABOLISM	SLC37A1 NUP43 NUP37 SLC37A2 ENO1 ENO2 ENO3	1.01e-05	85	125	7	M1870
Pathway	REACTOME_GLUCONEOGENESIS	SLC37A1 SLC37A2 ENO2 ENO3	7.57e-05	26	125	4	MM15392
Pathway	REACTOME_GLUCOSE_METABOLISM	SLC37A1 NUP43 NUP37 SLC37A2 ENO2 ENO3	8.70e-05	82	125	6	MM15394
Pathway	WP_IRON_METABOLISM_IN_PLACENTA	ACO1 IREB2 HEPHL1	1.41e-04	12	125	3	M39660
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	SLC37A1 NUP43 RHCE NUP37 HS6ST1 SLC37A2 HS6ST3 ENO1 ENO2 ENO3	2.43e-04	288	125	10	M16864
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIP1 ANKS6 VWA8 POLG COX6A1 AGPAT2 IPP AKNA GRID1 ZNF395 RALGAPA2 BIRC6 SYNE4 ELAC2 KCNH3 GAS2L1 FZR1 CELSR1 SLC12A4 SBF1 MEGF8 SND1 CANT1 KLHL36 NBEAL2 TNKS1BP1 WDR90 HTT	5.29e-13	1105	166	28	35748872
Pubmed	Gas2l3, a novel constriction site-associated protein whose regulation is mediated by the APC/C Cdh1 complex.	GAS2L3 APC FZR1	1.07e-07	3	166	3	23469016
Pubmed	A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA.	ENO1 ENO2 ENO3	4.26e-07	4	166	3	25918939
Pubmed	Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina.	ACO1 IREB2 HEPH	4.26e-07	4	166	3	15354085
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	GRID1 RALGAPA2 BIRC6 KCNH3 FZR1 KIDINS220 AARS2	6.70e-07	103	166	7	10574462
Pubmed	Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo.	CDO1 SPAG9 CDON	1.06e-06	5	166	3	17074887
Pubmed	Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells.	ENO1 ENO2 ENO3	2.11e-06	6	166	3	19433310
Pubmed	Cdo binds Abl to promote p38alpha/beta mitogen-activated protein kinase activity and myogenic differentiation.	CDO1 SPAG9 CDON	2.11e-06	6	166	3	19470755
Pubmed	A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta MAPK activity and myogenic differentiation.	CDO1 SPAG9 CDON	3.69e-06	7	166	3	18678706
Pubmed	Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains.	APC OTUD7B OTUD7A	3.69e-06	7	166	3	18281465
Pubmed	Systematic identification of molecular links between core and candidate genes in breast cancer.	APC FZR1 PRSS50 KLK9 ENO1 ENO2 DKK3 FBXW7	4.61e-06	194	166	8	25640309
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 VWA8 BMS1 AKNA HEPH SBF1 PPM1F NBEAL2 TNKS1BP1 WDR90 ANKS3 NIN	9.91e-06	529	166	12	14621295
Pubmed	Subcellular localization of iron regulatory proteins to Golgi and ER membranes.	ACO1 IREB2	2.26e-05	2	166	2	16144863
Pubmed	Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism.	ACO1 IREB2	2.26e-05	2	166	2	15866737
Pubmed	A regulated RNA binding protein also possesses aconitase activity.	ACO1 IREB2	2.26e-05	2	166	2	1946430
Pubmed	Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.	ENO1 ENO2	2.26e-05	2	166	2	30779465
Pubmed	Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.	ACO1 IREB2	2.26e-05	2	166	2	14726953
Pubmed	Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins.	ACO1 IREB2	2.26e-05	2	166	2	17200797
Pubmed	HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system.	HIP1 HTT	2.26e-05	2	166	2	9147654
Pubmed	Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1.	HLA-E HLA-G	2.26e-05	2	166	2	16362895
Pubmed	Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?	HLA-E HLA-G	2.26e-05	2	166	2	17768067
Pubmed	Human Amnion Epithelial Cells Impair T Cell Proliferation: The Role of HLA-G and HLA-E Molecules.	HLA-E HLA-G	2.26e-05	2	166	2	32961693
Pubmed	Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development.	ENO1 ENO3	2.26e-05	2	166	2	2090519
Pubmed	Male hypogonadism and germ cell loss caused by a mutation in Polo-like kinase 4.	GATA4 PLK4	2.26e-05	2	166	2	21791561
Pubmed	Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.	HLA-E HLA-G	2.26e-05	2	166	2	24196788
Pubmed	In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation.	ACO1 IREB2	2.26e-05	2	166	2	19533074
Pubmed	Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.	ACO1 IREB2	2.26e-05	2	166	2	15831703
Pubmed	Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways.	PRKCH PRKD1	2.26e-05	2	166	2	11741879
Pubmed	Cloning and characterization of a putative human glycerol 3-phosphate permease gene (SLC37A1 or G3PP) on 21q22.3: mutation analysis in two candidate phenotypes, DFNB10 and a glycerol kinase deficiency.	SLC37A1 SLC37A2	2.26e-05	2	166	2	11112347
Pubmed	FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.	ENO1 FBXW7	2.26e-05	2	166	2	26097998
Pubmed	Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.	ACO1 IREB2	2.26e-05	2	166	2	25771171
Pubmed	Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements.	ACO1 IREB2	2.26e-05	2	166	2	8262972
Pubmed	Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.	ACO1 IREB2	2.26e-05	2	166	2	16503547
Pubmed	[Expression of the molecules HLA-G and HLA-E modulates cytokine production of monocyte generated dendritic cells].	HLA-E HLA-G	2.26e-05	2	166	2	12232815
Pubmed	Self-association and ligand-induced conformational changes of iron regulatory proteins 1 and 2.	ACO1 IREB2	2.26e-05	2	166	2	15938636
Pubmed	Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.	HLA-E HLA-G	2.26e-05	2	166	2	29499226
Pubmed	Iron regulatory proteins secure mitochondrial iron sufficiency and function.	ACO1 IREB2	2.26e-05	2	166	2	20674864
Pubmed	Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients.	HLA-E HLA-G	2.26e-05	2	166	2	25461612
Pubmed	HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group.	HLA-E HLA-G	2.26e-05	2	166	2	11137220
Pubmed	HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages.	ENO1 ENO2	2.26e-05	2	166	2	17922513
Pubmed	Cloning of the cDNA encoding an RNA regulatory protein--the human iron-responsive element-binding protein.	ACO1 IREB2	2.26e-05	2	166	2	2172968
Pubmed	The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G.	HLA-E HLA-G	2.26e-05	2	166	2	7751618
Pubmed	HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma.	HLA-E HLA-G	2.26e-05	2	166	2	22640987
Pubmed	Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.	HLA-E HLA-G	2.26e-05	2	166	2	23625177
Pubmed	ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice.	ANKS6 ANKS3	2.26e-05	2	166	2	26327442
Pubmed	Linkage disequilibrium between HLA-G0104 and HLA-E0103 alleles in Tswa Pygmies.	HLA-E HLA-G	2.26e-05	2	166	2	21299523
Pubmed	P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc(Min/+) Mice.	SELP APC	2.26e-05	2	166	2	25999791
Pubmed	Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?	HLA-E HLA-G	2.26e-05	2	166	2	20167379
Pubmed	Sonic Hedgehog promotes tumor cell survival by inhibiting CDON pro-apoptotic activity.	APC CDON	2.26e-05	2	166	2	23940460
Pubmed	Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines.	APC FBXW7	2.26e-05	2	166	2	23676439
Pubmed	Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3.	ANKS6 ANKS3	2.26e-05	2	166	2	24998259
Pubmed	Human Antigen Leucocyte (HLA)-G and HLA-E are differentially expressed in pancreatic disorders.	HLA-E HLA-G	2.26e-05	2	166	2	31561913
Pubmed	The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation.	ACO1 IREB2	2.26e-05	2	166	2	8041788
Pubmed	Over-expression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas.	APC PVR	2.26e-05	2	166	2	8980189
Pubmed	HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.	HLA-E HLA-G	2.26e-05	2	166	2	21057081
Pubmed	Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain.	ENO1 ENO2	2.26e-05	2	166	2	2362815
Pubmed	Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos.	HLA-E HLA-G	2.26e-05	2	166	2	20113960
Pubmed	Generation of conditional alleles of the murine Iron Regulatory Protein (IRP)-1 and -2 genes.	ACO1 IREB2	2.26e-05	2	166	2	16283625
Pubmed	Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis.	PRKCH PRKD1	2.26e-05	2	166	2	10867018
Pubmed	Iron regulatory proteins 1 and 2 have opposing roles in regulating inflammation in bacterial orchitis.	ACO1 IREB2	2.26e-05	2	166	2	38301068
Pubmed	Medial amygdalar aromatase neurons regulate aggression in both sexes.	GAD1 CYP19A1	2.26e-05	2	166	2	25620703
Pubmed	Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.	ENO1 ENO2	2.26e-05	2	166	2	22551201
Pubmed	Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver.	HLA-E HLA-G	2.26e-05	2	166	2	1624808
Pubmed	GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.	GATA4 DKK3	2.26e-05	2	166	2	27788486
Pubmed	Complete structure of the human gene encoding neuron-specific enolase.	ENO1 ENO2	2.26e-05	2	166	2	2045099
Pubmed	[Relationship of human leucocyte antigen G, E with intrahepatic cholestasis of pregnancy].	HLA-E HLA-G	2.26e-05	2	166	2	17953356
Pubmed	[The expression of human leukocyte antigen G and E on human first trimester placenta and its relationship with recurrent spontaneous abortion].	HLA-E HLA-G	2.26e-05	2	166	2	19253840
Pubmed	Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo.	ACO1 IREB2	2.26e-05	2	166	2	15208438
Pubmed	In vivo and in vitro inhibition of cyp19 gene expression by prostaglandin F2alpha in murine luteal cells: implication of GATA-4.	CYP19A1 GATA4	2.26e-05	2	166	2	15271885
Pubmed	Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide.	ACO1 IREB2	2.26e-05	2	166	2	21566147
Pubmed	Isolation of murine neuron-specific and non-neuronal enolase cDNA clones.	ENO1 ENO2	2.26e-05	2	166	2	3801001
Pubmed	Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients.	HLA-E HLA-G	2.26e-05	2	166	2	27610393
Pubmed	Excess capacity of the iron regulatory protein system.	ACO1 IREB2	2.26e-05	2	166	2	17604281
Pubmed	FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.	APC FBXW7	2.26e-05	2	166	2	21282377
Pubmed	Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins.	ENO1 ENO3	2.26e-05	2	166	2	9169614
Pubmed	Replacement of charged and polar residues in the coiled-coiled interface of huntingtin-interacting protein 1 (HIP1) causes aggregation and cell death.	HIP1 HTT	2.26e-05	2	166	2	22835334
Pubmed	Genetic polymorphism of the iron-regulatory protein-1 and -2 genes in age-related macular degeneration.	ACO1 IREB2	2.26e-05	2	166	2	22331484
Pubmed	Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation.	ACO1 IREB2	2.26e-05	2	166	2	7983023
Pubmed	Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue.	HLA-E HLA-G	2.26e-05	2	166	2	2249951
Pubmed	HLA-G and HLA-E in patients with juvenile idiopathic arthritis.	HLA-E HLA-G	2.26e-05	2	166	2	21186170
Pubmed	Distribution of HLA-G extended haplotypes and one HLA-E polymorphism in a large-scale study of mother-child dyads with and without severe preeclampsia and eclampsia.	HLA-E HLA-G	2.26e-05	2	166	2	27596021
Pubmed	Primate Mhc-E and -G alleles.	HLA-E HLA-G	2.26e-05	2	166	2	9218527
Pubmed	Iron regulatory proteins increase neuronal vulnerability to hydrogen peroxide.	ACO1 IREB2	2.26e-05	2	166	2	18655771
Pubmed	Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D.	KIDINS220 PRKD1	2.26e-05	2	166	2	10998417
Pubmed	Effects of iron regulatory protein regulation on iron homeostasis during hypoxia.	ACO1 IREB2	2.26e-05	2	166	2	12855587
Pubmed	Fibre-type distribution and subcellular localisation of alpha and beta enolase in mouse striated muscle.	ENO1 ENO3	2.26e-05	2	166	2	11229603
Pubmed	Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo.	ACO1 IREB2	2.26e-05	2	166	2	15604406
Pubmed	Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?	HLA-E HLA-G	2.26e-05	2	166	2	20667016
Pubmed	Passenger deletions generate therapeutic vulnerabilities in cancer.	ENO1 ENO2	2.26e-05	2	166	2	22895339
Pubmed	Diurnal control of iron responsive element containing mRNAs through iron regulatory proteins IRP1 and IRP2 is mediated by feeding rhythms.	ACO1 IREB2	2.26e-05	2	166	2	38773499
Pubmed	HLA-E0101 and HLA-G010101 reduce the risk of Behcet's disease.	HLA-E HLA-G	2.26e-05	2	166	2	17257316
Pubmed	The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping.	HLA-E HLA-G RHCE	2.28e-05	12	166	3	10495887
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	ELAPOR2 GAS2L3 PARP2 GATA4 APC XPO1 OTUD7B WDR74 AARS2 SBF1 DENND4B TAF2 ENO1	2.92e-05	689	166	13	36543142
Pubmed	The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions.	NUP43 XPO1 NUP37	3.74e-05	14	166	3	17363900
Pubmed	Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues.	HIP1 GATA4 HTT	4.66e-05	15	166	3	9502734
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	HIP1 VWA8 PARP2 COX6A1 CARS1 GRID1 ATP10B SPAG9 KCNH3 KLHL36 NBEAL2 PRSS50 HS6ST3 ENO3	4.98e-05	832	166	14	36724073
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ENTPD7 AGPAT2 HLA-E FSTL4 CPD TMEM38B ELAC2 DMXL1 CELSR1 GTF3C1 MOGS MEGF8 CANT1 PVR TNKS1BP1 HTT CDON	6.67e-05	1201	166	17	35696571
Pubmed	Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum.	ACO1 IREB2	6.77e-05	3	166	2	18177727
Pubmed	The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides.	HLA-E HLA-G	6.77e-05	3	166	2	10430630
Pubmed	Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.	ENO2 ENO3	6.77e-05	3	166	2	22087329
Interaction	TOP3B interactions	HIP1 ANKS6 VWA8 POLG COX6A1 AGPAT2 IPP AKNA IREB2 GRID1 ZNF395 RALGAPA2 BIRC6 SYNE4 ELAC2 KCNH3 GAS2L1 FZR1 CELSR1 SLC12A4 MOGS SBF1 MEGF8 SND1 CANT1 KLHL36 NBEAL2 TNKS1BP1 WDR90 HTT	1.93e-06	1470	162	30	int:TOP3B
GeneFamily	WD repeat domain containing	NWD1 EML6 NUP43 WDR76 WDFY2 DMXL1 WDR74 FZR1 EML5 NUP37 NBEAL2 WDR90 NSMAF FBXW7	8.63e-10	262	112	14	362
Coexpression	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	SELP RALGAPA1 CARS1 APC ELAC2 FZR1 PPM1F PRKCH CDON	4.80e-06	199	164	9	M7099
Coexpression	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP	SELP HLA-G CPD FBXO30 SLC12A4 GFOD1 ENO2 ENO3 NSMAF	5.00e-06	200	164	9	M9169
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	OGT GAS2L3 POLG HLA-E HLA-G CPD DNAJC22 ATP10D FZR1 GTF3C1 SLC12A4 MOGS SBF1 CANT1 SLC9A6 HTT	9.39e-06	703	164	16	MM1055
Coexpression	GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP	HIP1 ACO1 OTUD7B GFOD1 NBEAL2 GZMA SLC25A53 FBXW7	1.52e-05	175	164	8	M6690
Coexpression	GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN	RALGAPA1 GAS2L3 TRPM2 IREB2 SSC4D KNDC1 ENO1 NIN	3.81e-05	199	164	8	M4847
Coexpression	GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP	CYP19A1 APC CPD TMEM38B FGL2 PRKCH ENO3 NSMAF	3.95e-05	200	164	8	M7282
Coexpression	GSE3982_MAC_VS_BASOPHIL_UP	RALGAPA1 MATK DMXL1 GFOD1 PPM1F PRSS50 ENO1 NSMAF	3.95e-05	200	164	8	M5496
Coexpression	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP	LYPLAL1 POLG AGPAT2 DGKG VSIG10 WDFY2 SLC25A53 WDR90	3.95e-05	200	164	8	M5698
ToppCell	Control-Lymphocyte-T_NK-MAIT\|Control / Disease, Lineage and Cell Type	MATK CYP19A1 ATP10B TOMM20L GTF3C1 GZMA GZMM DKK3 CDON	1.53e-08	169	166	9	8c2aac193a9c500f01a99a2ee530839c851b6222
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-gdT\|Multiple_Sclerosis / Disease, Lineage and Cell Type	MATK HLA-E HLA-G GTF3C1 GZMA GZMM PRKCH EPHX4	3.79e-07	179	166	8	ab8d8104b38603ec7fbc5b35d7149e71ad57c43a
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK TRPM2 HLA-E GZMA GZMM PRKCH DKK3 KLHL4	5.72e-07	189	166	8	e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	MATK AKNA GTF3C1 GFOD1 GZMA GZMM KANK4 PRKCH	5.95e-07	190	166	8	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	mild_COVID-19-gd_T\|mild_COVID-19 / disease group, cell group and cell class (v2)	RALGAPA1 MATK AKNA GTF3C1 GZMA GZMM PRKCH EPHX4	6.19e-07	191	166	8	0e43c097b92aaa831811d60e033262999e79dcd7
ToppCell	(210)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	MATK AKNA GTF3C1 ARHGEF10 GZMA GZMM PRKCH ANKS3	6.44e-07	192	166	8	08dc0c019c594da7b9944db8fd706aa7780e6ae9
ToppCell	mild_COVID-19-gd_T\|World / disease group, cell group and cell class (v2)	RALGAPA1 MATK AKNA GTF3C1 GZMA GZMM PRKCH EPHX4	6.44e-07	192	166	8	6912283dbd73285b6e0c653b2dd34c31337b9f1e
ToppCell	(21)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	MATK AKNA GTF3C1 ARHGEF10 GZMA GZMM PRKCH ANKS3	6.44e-07	192	166	8	b0a573ddde2978485a857b8261ee1ee5ef68ecef
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.44e-07	192	166	8	1922b0350d3375e67c314dbce8074e5cf986f2ef
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.44e-07	192	166	8	97c197643e59835c6d45dde9e549c9a1b1bb7288
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.44e-07	192	166	8	a4d161e3d48bc020e687808b352325ef9d1cc1f3
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.70e-07	193	166	8	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	MATK AKNA CPD GTF3C1 GFOD1 GZMA GZMM PRKCH	6.97e-07	194	166	8	c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.97e-07	194	166	8	fa72c2f3e6b8bfc2ef126deb219ec6a44809385b
ToppCell	T/NK_cells-NKT_cell\|World / Lineage and Cell class	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH EPHX4	6.97e-07	194	166	8	8e09989ec2d1bbfe70cb18321c2ae94e0d0d9f18
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.97e-07	194	166	8	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.97e-07	194	166	8	bc7c4efe2a82057fb95582da983e36f413990902
ToppCell	(1)_T_cells-(1)_T_CD8_activated\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH DKK3	6.97e-07	194	166	8	e3f288b58525c1f34db4459d3e83e0df695adfc7
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	6.97e-07	194	166	8	b43788e458a80ab93f485f4577370aec448ad95e
ToppCell	10x5'-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	MATK AKNA CPD GTF3C1 GFOD1 GZMA GZMM PRKCH	7.24e-07	195	166	8	c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCell	T/NK_cells-CD56dim_NK_cell\|World / Lineage and Cell class	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	7.24e-07	195	166	8	6124e87cb9061bf8918377fb4a79084079ddfc16
ToppCell	(0)_NK_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	7.53e-07	196	166	8	9b080859130cf156bfa833dc71fd39734cb9a32d
ToppCell	(1)_T_cells-(1)_T_CD8_CTL\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MATK HLA-E AKNA FGL2 GTF3C1 GZMA GZMM EPHX4	7.53e-07	196	166	8	ad9b0651cb2a15b750e453b2dcf782bca08b4fe7
ToppCell	(0)_NK\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	7.53e-07	196	166	8	e2578a562d9903a33a7c60db229005680af8141c
ToppCell	tumor_Lung-T/NK_cells-NK\|tumor_Lung / Location, Cell class and cell subclass	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	7.53e-07	196	166	8	006e630f3d8033f45c6b7e9154d77000c7b0cb70
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	7.53e-07	196	166	8	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	normal_Lung-T/NK_cells-NK\|normal_Lung / Location, Cell class and cell subclass	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	7.82e-07	197	166	8	6045a05a5f1073d683806eb46a3fa98358414625
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-NK\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	8.12e-07	198	166	8	e39ef71f3a9e0591bc0300ae132036fe2f8d5716
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	8.44e-07	199	166	8	b03539908131308d7bf5036e78c4c840a6a79a17
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	8.44e-07	199	166	8	7d071c88a003babf6dbdb84dde561fc03c92f375
ToppCell	normal_Lung-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	8.44e-07	199	166	8	407ae8575bb4dec7fe10d48ceb8f32a03f5ac1bb
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-NK\|ICU-SEP / Disease, condition lineage and cell class	NEIL1 MATK GTF3C1 GFOD1 ARHGEF10 GZMA GZMM PRKCH	8.76e-07	200	166	8	6813fa6d24950fac22e2b5bb26b64f79214163b6
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-gd_T\|Multiple_Sclerosis / Disease, condition lineage and cell class	MATK HLA-E HLA-G GTF3C1 GZMA GZMM PRKCH EPHX4	8.76e-07	200	166	8	498a2632b111fbf2cd4d755e53698ac5573ba763
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	GAD1 MATK ITGA10 CSMD2 KNDC1 EBF4 FBXW7 KLHL4	8.76e-07	200	166	8	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D\|390C / Donor, Lineage, Cell class and subclass (all cells)	NEIL1 MATK HLA-E GFOD1 GZMA GZMM PRKCH	2.48e-06	161	166	7	b60b4fd34a3ad4bf1813e6cc24aa7e04f9e53e4c
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ANKS6 ITLN1 VSIG10 ATP10D SLC25A53 TNKS1BP1 ENO2	2.80e-06	164	166	7	d6806deabf5f5c355934387be2baae125ac33fb8
ToppCell	droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELAPOR2 ADAM23 SMYD1 TM4SF5 VSIG10 PVR ENO2	2.80e-06	164	166	7	78de403446fe0eb375c82ff1832cc5fbb8e20afa
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATK IREB2 CD163 ADAMTS16 SLC39A5 MAP4K2 CDON	3.04e-06	166	166	7	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATK IREB2 CD163 ADAMTS16 SLC39A5 MAP4K2 CDON	3.04e-06	166	166	7	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GAD1 FSTL4 WDFY2 SSC4D ADAMTS16 ADAMTS17 KNDC1	3.99e-06	173	166	7	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	MATK AKNA MEGF8 GZMA GZMM IL9R NIN	5.18e-06	180	166	7	f24d4cbba4cb50fce3b3d9c4629aa856d9b05358
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GAD1 FSTL4 WDFY2 SSC4D ADAMTS16 ADAMTS17 KNDC1	5.37e-06	181	166	7	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GAD1 HLA-E RALGAPA2 RHCE MAP4K2 DKK3 KLHL4	5.78e-06	183	166	7	a90ffd9c50caa65f537a2e441e37655e1b622327
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GAD1 HLA-E RALGAPA2 RHCE MAP4K2 DKK3 KLHL4	5.78e-06	183	166	7	13ad20ec140ef5b96fdace3369b5befc0f40bb76
ToppCell	tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T\|tumor_Lung / Location, Cell class and cell subclass	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	6.65e-06	187	166	7	530839fb53bb285b22919fde6aa16ce1399615ef
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	ELAC2 ARL5B SLC12A4 DENND4B HTT IL9R NIN	6.89e-06	188	166	7	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK HLA-E AKNA OR10G3 GZMA GZMM PRKCH	7.13e-06	189	166	7	f1129eb122bbc051457c5545f1a267beb988b0f2
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK HLA-E AKNA OR10G3 GZMA GZMM PRKCH	7.13e-06	189	166	7	0b012ee301419fa9ccc387c3ff66c2344b349a97
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	MATK AKNA FGL2 GTF3C1 GZMA GZMM ANKS3	7.13e-06	189	166	7	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	MATK AKNA FGL2 GTF3C1 GZMA GZMM ANKS3	7.13e-06	189	166	7	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ANKS6 ITLN1 VSIG10 ATP10D TNKS1BP1 ENO2	7.52e-06	125	166	6	43aa4b77dccf0ea2979218826af16034f2017c3a
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK HLA-E GTF3C1 GZMA GZMM PRKCH EPHX4	7.64e-06	191	166	7	b2d0ea24970da09209da9d9dda76e30fbfe22917
ToppCell	Control-Lymphoid-ILC_A\|Control / Disease state, Lineage and Cell class	MATK AKNA GZMA GZMM ADAMTS17 KANK4 PRKCH	7.64e-06	191	166	7	1ca73582dc3d28322b5ee841010067589d848acc
ToppCell	BLOOD--(1)_gd_T_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MATK HLA-G GTF3C1 GZMA GZMM PRKCH EPHX4	7.64e-06	191	166	7	47ced00ed6fb47ddc6e9baa76186ea974720defd
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK AKNA GZMA GZMM PRKCH DKK3 KLHL4	7.64e-06	191	166	7	f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK AKNA GZMA GZMM PRKCH DKK3 KLHL4	7.90e-06	192	166	7	4d72b9264ed62e0c08cde4078061b348253f6989
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK HLA-E AKNA GZMA GZMM PRKCH DKK3	7.90e-06	192	166	7	7a122505d7adf236e0cbd9bcbc98e7c537600ca3
ToppCell	normal_Pleural_Fluid-T/NK_cells-Naive_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	MATK HLA-E AKNA ARHGEF10 GZMA GZMM DKK3	8.18e-06	193	166	7	75a0b3aa40bdb844dc48c2b6ad945c73e47b60d4
ToppCell	normal_Pleural_Fluid-T/NK_cells-Naive_CD8+_T\|normal_Pleural_Fluid / Location, Cell class and cell subclass	MATK HLA-E AKNA GZMA GZMM PRKCH DKK3	8.18e-06	193	166	7	828f11c9081df74faf3b788456991e1a0cf99900
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NT5E HLA-E DCST1 PPM1F PRKCH MAP4K2 KLHL4	8.18e-06	193	166	7	807fa1443b3c883cb318c71f4fca3c41d58f4910
ToppCell	3'_v3-Lung-Lymphocytic_NK\|Lung / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	8.18e-06	193	166	7	a98ee519e0da93ae4a2dcdda1ee8b4138dec131b
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SELP ADAM23 GRID1 ADAMTS16 PRKD1 MN1 KLHL4	8.18e-06	193	166	7	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH	8.18e-06	193	166	7	db9378c5bb5c27b321957a05dcabf40e97a3b725
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK\|ICU-SEP / Disease, Lineage and Cell Type	MATK GTF3C1 GFOD1 ARHGEF10 GZMA GZMM PRKCH	8.18e-06	193	166	7	f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MATK HLA-E AKNA GZMA GZMM PRKCH DKK3	8.18e-06	193	166	7	30db4ddfdeb225cc934cf52af1fbcccfdaeb6223
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	8.46e-06	194	166	7	8bfd7c5be518b81b17913139bcb3ebea01f48dd5
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	8.46e-06	194	166	7	3337042eef91a49f621058785723228cf4dfdad4
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK AKNA GTF3C1 GZMA GZMM PRKCH EPHX4	8.46e-06	194	166	7	ecdfc27d06e363fb23f0309f26ef6404a89f14ec
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK HLA-E AKNA GZMA GZMM PRKCH DKK3	8.46e-06	194	166	7	68e9ad254fe94e2f59cf5c2b2ea3e1245cb85104
ToppCell	normal_Lymph_Node-T/NK_cells-Naive_CD8+_T\|normal_Lymph_Node / Location, Cell class and cell subclass	MATK HLA-E AKNA GZMA GZMM PRKCH DKK3	8.46e-06	194	166	7	81b8f60d3b81e494051721ce9b8b6aefd415442c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	8.46e-06	194	166	7	f0707601883b234ed477c7704ca9a88efaefc3fd
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK HLA-E GTF3C1 GFOD1 GZMA GZMM PRKCH	8.46e-06	194	166	7	ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK HLA-E GTF3C1 GFOD1 GZMA GZMM PRKCH	8.46e-06	194	166	7	3a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH	8.74e-06	195	166	7	e1b7ef4ba2ab14d3c839b6305d91efcfd0826220
ToppCell	IIF-Lymphocyte-T_NK-NK\|IIF / Disease, Lineage and Cell Type	MATK HLA-E GTF3C1 GFOD1 GZMA GZMM PRKCH	8.74e-06	195	166	7	464ce05cb52f78aee22d3baa6641b37bd53aae16
ToppCell	(1)_T_CD8_CTL\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MATK HLA-E AKNA GZMA GZMM PRKCH EPHX4	8.74e-06	195	166	7	f582b854e5a4c52764aad5abe4e28ea77a7445f7
ToppCell	3'-Distal_airway-Immune_Lymphocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH	8.74e-06	195	166	7	4a60b51f92830882872f2fe1a911db2970faf071
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM	8.74e-06	195	166	7	e756733cf48768bf40058d6cf9039e52f7563133
ToppCell	10x5'-Lung-Lymphocytic_NK\|Lung / Manually curated celltypes from each tissue	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH	8.74e-06	195	166	7	a5a10ef9254c266316e5591bec19e159cc3caead
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	8.74e-06	195	166	7	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	(1)_T_CD8_activated\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MATK HLA-E AKNA GZMA GZMM PRKCH DKK3	8.74e-06	195	166	7	2253590339b87692d350f9ea3d2aa851179967e1
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK AKNA GFOD1 GZMA GZMM ADAMTS17 PRKCH	9.04e-06	196	166	7	93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2
ToppCell	ILEUM-inflamed-(1)_Cytotoxic_T_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MATK AKNA GTF3C1 GZMA GZMM PRKCH DKK3	9.04e-06	196	166	7	42d807605c6103fc80f038f4a351e89981533669
ToppCell	Healthy/Control-gd_T\|Healthy/Control / Disease group and Cell class	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	9.04e-06	196	166	7	a6f9e55cd1cd7facadb3f508bded68023c997f3f
ToppCell	metastatic_Lymph_Node-T/NK_cells-NK\|metastatic_Lymph_Node / Location, Cell class and cell subclass	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH	9.04e-06	196	166	7	f69f53e2ac1818b4ad0161b0bd70655e98ef65f0
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK AKNA GTF3C1 GFOD1 GZMA GZMM PRKCH	9.04e-06	196	166	7	5b5cf6f70534661d694f47359b6595b4580876c3
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	9.04e-06	196	166	7	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	ILEUM-non-inflamed-(6)_ILC-(6)_ILC1\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RALGAPA1 OGT MATK AKNA GFOD1 GZMA GZMM	9.04e-06	196	166	7	8a3a63129adfbe58558af91336f81d397c291ed0
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	9.04e-06	196	166	7	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	9.04e-06	196	166	7	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	9.04e-06	196	166	7	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MATK HLA-E AKNA GFOD1 GZMA GZMM PRKCH	9.04e-06	196	166	7	772a5851cbcc36b2075bd2ffbf8c9afa9b4b6eb7
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	MATK HLA-E GTF3C1 GFOD1 GZMA GZMM PRKCH	9.04e-06	196	166	7	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK HLA-E GTF3C1 GFOD1 GZMA GZMM PRKCH	9.35e-06	197	166	7	76304df40f87224f8e415677e3ee8fb183fe0c03
ToppCell	tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lung / Location, Cell class and cell subclass	RALGAPA1 HLA-E AKNA WDR74 GZMA GZMM PRKCH	9.35e-06	197	166	7	de26ca046038e34790cece24529a05d491e6f8ef
ToppCell	356C-Lymphocytic-NK_cells\|356C / Donor, Lineage, Cell class and subclass (all cells)	MATK HLA-E GTF3C1 GFOD1 GZMA GZMM PRKCH	9.35e-06	197	166	7	ae55ac5c714e55061d605dee030cbe29b43cf9c1
ToppCell	10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8\|blood / Manually curated celltypes from each tissue	MATK HLA-E AKNA GTF3C1 GZMA GZMM PRKCH	9.35e-06	197	166	7	13e6611cde9364f0c1bf681b0b26c4d2725e5f4a
ToppCell	tumor_Lung-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	MATK HLA-E AKNA GTF3C1 GFOD1 GZMA GZMM	9.35e-06	197	166	7	e9fac2c923179b2b8b0500076421c6fb09960b56
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MATK AKNA GFOD1 GZMA GZMM ADAMTS17 PRKCH	9.35e-06	197	166	7	e8861abffbb7169f1923fad6e565865eee22f310
ToppCell	severe_influenza-NK\|World / disease group, cell group and cell class (v2)	MATK GTF3C1 GFOD1 GZMA GZMM PRKCH KLHL4	9.35e-06	197	166	7	8e86a1ee0418e153d4f0bf291006cffc6cf36f71
Computational	Neighborhood of MATK	MATK GZMA GZMM PRKCH	5.31e-05	24	95	4	GNF2_MATK
Computational	Neighborhood of ZAP70	MATK GZMA GZMM PRKCH	7.37e-05	26	95	4	GNF2_ZAP70
Drug	N-succinylphenylglycine	ENO1 ENO2 ENO3	3.81e-07	3	166	3	CID000448582
Drug	AC1MOUJL	ENO1 ENO2 ENO3	3.81e-07	3	166	3	CID003400924
Drug	C03356	ENO1 ENO2 ENO3	3.81e-07	3	166	3	CID000439988
Drug	3-bromo-2-(bromomethyl)propionic acid	ENO1 ENO2 ENO3	3.81e-07	3	166	3	CID000318915
Drug	C04309	ENO1 ENO2 ENO3	3.81e-07	3	166	3	CID000440293
Drug	2,3-diketo-1-phosphohexane	ENO1 ENO2 ENO3	3.81e-07	3	166	3	CID000192519
Drug	dimethyl chlorophosphate	ENO1 ENO2 ENO3	1.51e-06	4	166	3	CID000101863
Drug	[2-(oxidoamino)-2-oxoethyl]phosphonic acid	ENO1 ENO2 ENO3	1.51e-06	4	166	3	CID011969443
Drug	3-aminoenolpyruvate-2-phosphate	ENO1 ENO2 ENO3	1.51e-06	4	166	3	CID003037152
Drug	2-ptz	ENO1 ENO2 ENO3	1.51e-06	4	166	3	CID000445375
Drug	tricyclohexylammonium	ENO1 ENO2 ENO3	1.51e-06	4	166	3	CID000226271
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A	GATA4 APC TM4SF5 GAS2L1 FZR1 KIDINS220 TESMIN MEGF8 ARHGEF10 C1QTNF3	2.21e-06	200	166	10	5917_DN
Drug	reductone	CDO1 XPO1 ENO1 ENO2 ENO3	2.38e-06	30	166	5	CID003034155
Drug	N-methylacrylamide	ENO1 ENO2 ENO3	3.77e-06	5	166	3	CID000014471
Drug	AC1L1CAI	ENO1 ENO2 ENO3	3.77e-06	5	166	3	CID000000145
Drug	tartronate semialdehyde phosphate	ENO1 ENO2 ENO3	3.77e-06	5	166	3	CID000151938
Drug	2-phospho-3-butenoic acid	ENO1 ENO2 ENO3	3.77e-06	5	166	3	CID000191423
Drug	1-Pdmsp	ENO1 ENO2 ENO3	3.77e-06	5	166	3	CID000000561
Drug	dimidium	ENO1 ENO2 ENO3	7.49e-06	6	166	3	CID000068207
Drug	Z(2-Cl)-OSu	ENO1 ENO2 ENO3	7.49e-06	6	166	3	CID000580665
Drug	4-(N,N-dimethylamino)cinnamoyl-CoA	ENO1 ENO2 ENO3	7.49e-06	6	166	3	CID000445461
Drug	N-tert-butylacrylamide	ENO1 ENO2 ENO3	1.30e-05	7	166	3	CID000007877
Drug	glycidol phosphate	ENO1 ENO2 ENO3	1.30e-05	7	166	3	CID000152659
Drug	lavendustin C6	ENO1 ENO2 ENO3	1.30e-05	7	166	3	CID000126839
Drug	CPEP	ENO1 ENO2 ENO3	1.30e-05	7	166	3	CID000360637
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	IPP TM4SF5 FZR1 SBF1 SND1 ARHGEF10 KLHL36 PVR ENO2	1.61e-05	199	166	9	6982_UP
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	GAD1 VWA8 TMEM38B FZR1 KIDINS220 SBF1 NBEAL2 PRKD1 CDON	1.61e-05	199	166	9	7380_DN
Drug	macrophomate	ENO1 ENO2 ENO3	2.08e-05	8	166	3	CID010889109
Drug	AC1L19IJ	ENO1 ENO2 ENO3	3.10e-05	9	166	3	CID000000562
Drug	AC1L1A4W	ENO1 ENO2 ENO3	3.10e-05	9	166	3	CID000000837
Drug	valienamine	HIP1 APC MOGS ENO1 ENO2 ENO3 SLC9A6	3.74e-05	125	166	7	CID000193758
Drug	silver nanoparticles	HIP1 ACO1 IREB2 ZNF395 TESMIN ENO2 HTT FBXW7	3.95e-05	172	166	8	CID000023954
Drug	pyrene-4,5-dione	ENO1 ENO2 ENO3	4.40e-05	10	166	3	CID000160814
Drug	L-fuconic acid	ENO1 ENO2 ENO3	4.40e-05	10	166	3	CID000345732
Drug	phosphoenolthiopyruvate	ENO1 ENO2 ENO3	4.40e-05	10	166	3	CID000194910
Drug	xylonate	ENO1 ENO2 ENO3	4.40e-05	10	166	3	CID000010264
Drug	Sch 47555	NT5E CYP19A1	5.28e-05	2	166	2	CID000122719
Drug	p-nitrophenylhydroxylamine	ACO1 IREB2	5.28e-05	2	166	2	CID005486551
Drug	Sch 47554	NT5E CYP19A1	5.28e-05	2	166	2	CID000192464
Drug	LG61	ENO1 ENO2 ENO3	7.98e-05	12	166	3	CID000520177
Drug	AC1L18ZV	ENO1 ENO2 ENO3	7.98e-05	12	166	3	CID000000329
Drug	m1 C	APC ENO1 ENO2 ENO3	8.36e-05	32	166	4	CID000448219
Drug	AC1Q5BXE	GAD1 ENO1 ENO2 ENO3	8.36e-05	32	166	4	CID000000037
Drug	Hcys	CDO1 CARS1 CD163 SLC12A4 TESMIN KLK9 PRKCH PRKD1 CDON	9.52e-05	250	166	9	CID000000594
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	EPHX2 GAD1 POLG AGPAT2 DMXL1 MOGS SBF1 PVR	9.54e-05	195	166	8	2104_DN
Drug	Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A	GAD1 DGKG WDR76 FZR1 TESMIN MEGF8 PVR CDON	9.54e-05	195	166	8	3335_UP
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ENTPD7 GAD1 POLG GATA4 APC FZR1 PVR CDON	9.88e-05	196	166	8	6506_DN
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	VWA8 APC FZR1 SBF1 SND1 PVR MN1 ENO2	9.88e-05	196	166	8	6299_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	APC IREB2 VPS13D SBF1 SND1 NBEAL2 MAP4K2 HTT	1.02e-04	197	166	8	2845_DN
Drug	Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ENTPD7 HIP1 MATK APC GAS2L1 VPS13D ENO2 PLK4	1.10e-04	199	166	8	7331_DN
Drug	AC1MMD6A	TENT4A NT5E CYP19A1 CELA1 KLK9	1.21e-04	66	166	5	CID003259138
Drug	B-43	ENO1 ENO2 ENO3	1.31e-04	14	166	3	CID006603792
Drug	Hecameg	ENO1 ENO2 ENO3	1.31e-04	14	166	3	CID002733955
Disease	myelodysplastic syndrome	GRID1 EYA2 TAF2	1.89e-05	10	162	3	EFO_0000198
Disease	progressive familial intrahepatic cholestasis (implicated_via_orthology)	ATP10B ATP10D	8.95e-05	3	162	2	DOID:0070221 (implicated_via_orthology)
Disease	brain disease (is_marker_for)	CD163 ENO2	1.78e-04	4	162	2	DOID:936 (is_marker_for)
Disease	mastiha supplement exposure measurement, interleukin-6 measurement	TRPM2 SND1	1.78e-04	4	162	2	EFO_0004810, EFO_0600067
Disease	Lipodystrophy	PARP2 AGPAT2	2.96e-04	5	162	2	C0023787
Disease	porphyria (implicated_via_orthology)	ACO1 IREB2	2.96e-04	5	162	2	DOID:13268 (implicated_via_orthology)
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-E HLA-G	6.18e-04	7	162	2	DOID:0081267 (implicated_via_orthology)
Disease	endometrial cancer (is_implicated_in)	CYP19A1 APC UGT1A1	1.02e-03	36	162	3	DOID:1380 (is_implicated_in)
Disease	Situs Inversus	ANKS6 ANKS3	1.59e-03	11	162	2	C0037221
Disease	Adenocarcinoma of large intestine	MATK APC PRKCH FBXW7	1.96e-03	96	162	4	C1319315
Disease	myeloid leukemia (is_implicated_in)	UGT1A1 MN1	2.25e-03	13	162	2	DOID:8692 (is_implicated_in)
Disease	Mood Disorders	GAD1 GPR50 POLG HTT IL9R	2.40e-03	168	162	5	C0525045
Disease	hepatocellular carcinoma (implicated_via_orthology)	POLG APC XPO1	2.49e-03	49	162	3	DOID:684 (implicated_via_orthology)
Disease	serum IgG glycosylation measurement	CDO1 SMYD1 ACO1 IREB2 RALGAPA2 SBF1 ADAMTS17 PRKD1 NSMAF	2.50e-03	523	162	9	EFO_0005193
Disease	anemia (implicated_via_orthology)	APC IREB2	3.00e-03	15	162	2	DOID:2355 (implicated_via_orthology)
Disease	Lipidemias	NEIL1 APC	3.86e-03	17	162	2	C1706412
Disease	posterior cingulate cortex volume measurement	SLC37A1 NIN	3.86e-03	17	162	2	EFO_0010324
Disease	Hyperlipidemia	NEIL1 APC	3.86e-03	17	162	2	C0020473
Disease	Carcinoma, Granular Cell	CYP19A1 APC PRKD1 ENO1	3.89e-03	116	162	4	C0205644
Disease	Adenocarcinoma, Tubular	CYP19A1 APC PRKD1 ENO1	3.89e-03	116	162	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	CYP19A1 APC PRKD1 ENO1	3.89e-03	116	162	4	C0205642
Disease	Carcinoma, Cribriform	CYP19A1 APC PRKD1 ENO1	3.89e-03	116	162	4	C0205643
Disease	Adenocarcinoma, Basal Cell	CYP19A1 APC PRKD1 ENO1	3.89e-03	116	162	4	C0205641
Disease	Adenocarcinoma	CYP19A1 APC PRKD1 ENO1	3.89e-03	116	162	4	C0001418
Disease	aspartate aminotransferase measurement	ENTPD7 FSTL4 IPP AKNA EYA2 BIRC6 CD163 TIAL1 SND1 GFOD1 NUP37 HEPHL1	4.33e-03	904	162	12	EFO_0004736
Disease	balding measurement	VWA8 RGS22 COX6A1 EML6 GRID1 XPO1 GTF3C1 PRKCH PRKD1 CDON NIN	4.47e-03	792	162	11	EFO_0007825
Disease	anorectal malformation	TRPM2 CSMD2	4.82e-03	19	162	2	MONDO_0019938
Disease	Bipolar Disorder	GAD1 GPR50 POLG TRPM2 HLA-E HLA-G GRID1 ARHGEF10	5.00e-03	477	162	8	C0005586
Disease	Acute Myeloid Leukemia, M1	GAS2L1 PVR MN1 ENO2	5.07e-03	125	162	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	GAS2L1 PVR MN1 ENO2	5.07e-03	125	162	4	C1879321
Disease	Depressive disorder	SELP GAD1 GRID1 CSMD2 ARHGEF10 HTT	5.37e-03	289	162	6	C0011581

Protein segments in the cluster

Peptide	Gene	Start	Entry
SHTTMIDGLGILGWG	ACO1	206	P21399
HGGLAWRLGSMDVQA	MAMDC4	921	Q6UXC1
GFLWIGSCTHQMGQI	ARHGEF10	921	O15013
WGGCIMEETGVSHSR	ADAM23	456	O75077
TGEGLCQGLEWMTSR	ARL5B	161	Q96KC2
VWLASGLDLSGHAGM	BIRC6	1186	Q9NR09
LVGNSTRMCGLDGHW	CSMD2	2806	Q7Z408
TRMCGLDGHWTGSLP	CSMD2	2811	Q7Z408
LDTVRGCSVGGWMTG	CARMIL2	381	Q6F5E8
MGDWNLLGGILEEVH	GJA10	1	Q969M2
TMCQVAGWGRTHNSA	GZMA	146	P12544
AGTRCSMAGWGLTHQ	GZMM	141	P51124
SMAGWGLTHQGGRLS	GZMM	146	P51124
MRESGAHVWGSSAAG	AMN	346	Q9BXJ7
SVMLSGLRVTDGEWH	CELSR1	1761	Q9NYQ6
WSGMRTTGQLRLAHG	BMS1	1126	Q14692
TGAQDGSVRMFEWGH	DMXL1	2761	Q9Y485
QENGWGVMVSHRSGE	ENO2	361	P09104
LMCLIGAVGHSIWNG	ATP10B	326	O94823
IMCLTGAVGHGIWLS	ATP10D	331	Q9P241
CQWQSGLMGKDGTRH	ADAMTS16	366	Q8TE57
CAGRSHIMSGEWVKG	ADAMTS17	406	Q8TE56
WGGVSQMGSVHEEGS	CCDC27	356	Q2M243
HVVATGGQDGMLSIW	NUP43	231	Q8NFH3
GSMSWISCRGISGGI	NWD1	751	Q149M9
MASLGDLVRAWHLGA	NOXA1	1	Q86UR1
SHITMVNGLGILGWG	IREB2	281	P48200
WTEIGNMITSRCEGG	IPP	566	Q9Y573
WGRVGKMGQHSLVAC	PARP2	151	Q9UGN5
EMVLIGCHGSGTVQW	KCNH3	1061	Q9ULD8
LMVSCNRLWVGTGNG	SPAG9	1151	O60271
VLAFWSHGMQGRSLD	MAP4K2	756	Q12851
SHTLQWMIGCDLGSD	HLA-G	116	P17693
DGNCLLHAASLGMWG	OTUD7B	191	Q6GQQ9
GILMGVAWTGGLLHS	OR4C15	141	Q8NGM1
AGSHTLQWMHGCELG	HLA-E	111	P13747
GGGWTLVASVHENDM	ITLN1	76	Q8WWA0
LKCGVNLEHRDMGGW	KIDINS220	91	Q9ULH0
TARGWHSMCSLGDSI	KLHL36	481	Q8N4N3
DHCGEMLWGLVRQGL	PRKD1	161	Q15139
MAGRGSLVSWRAFHG	MATK	1	P42679
PGMSSLQDRHGRTIW	NEIL1	266	Q96FI4
LHVRGRGDWVSCGAM	ENTPD7	371	Q9NQZ7
SKCVLIGHDWGGMIA	EPHX4	161	Q8IUS5
LHAMSIGGWDLSQLQ	GPR50	86	Q13585
WNESMHSLRISVGGL	CANT1	11	Q8WVQ1
HVDAAWGGGLLMSRK	GAD1	371	Q99259
HGCTAFGWMTLQGRK	POLG	911	P54098
SHVAVAWAGSLVLMG	MEGF8	281	Q7Z7M0
HTCGGTLIRQNWVMT	CELA1	46	Q9UNI1
GDGNCLLHAASLGMW	OTUD7A	206	Q8TE49
ILMGSVAVGSGLSWH	NUP37	291	Q8NFH4
VAGAWMAGSIHGALQ	OR10G3	146	Q8NGC4
MHGGLCARLAITSWV	OR2F1	136	Q13607
MHGGLCARLAITSWV	OR2F2	136	O95006
RNVTSLGKGGMIWDH	PLEKHM3	61	Q6ZWE6
VPHGTQCLAMGWGRV	PRTN3	146	P24158
SGAHGEEGSARMWKT	COX6A1	26	P12074
LGWEVDLSTHCGFMG	RALGAPA2	1681	Q2PPJ7
GEWGSHSVMLKSGTN	ELAPOR2	241	A8MWY0
WLHIGTMNGRRLQFG	KLHL4	456	Q9C0H6
GATWKTSLHMCDGRT	HS6ST1	201	O60243
GATWKTSLHMCDGRS	HS6ST3	261	Q8IZP7
MQIWETSQGVGRGGS	TENT4A	1	Q5XG87
GMGCRPFHGWTSLVL	MOGS	816	Q13724
AHMGSHGKWGSVRTS	SBF1	1271	O95248
DEVWLRMGNGALHGD	C1QTNF3	216	Q9BXJ4
RDGFVSLQEWVHGGM	DGKG	236	P49619
GAMSTPLWRRDGTGH	GATA4	221	P43694
MLEGHTARVGALAWN	FZR1	266	Q9UM11
LIMGVWNSHTSVGNI	SLC37A1	191	P57057
MGIWNSHTSVGNILG	SLC37A2	181	Q8TED4
TMGLWVDCRGHGLTA	GP9	31	P14770
QANGWGVMVSHRSGE	ENO1	361	P06733
STHLQAENLMCWGTG	ADAM30	576	Q9UKF2
HVGDWMGTIRTLTGN	HTT	786	P42858
LSQAVFIGHDWGGML	EPHX2	326	P34913
GGRCWVTRHAVESLM	CARD14	881	Q9BXL6
SHGRFLWMGIGSACN	CYP19A1	61	P11511
GSVRSWMQGAGILDA	EBF4	26	Q9BQW3
AMGWGTSPHIRCASL	DCST1	91	Q5T197
MATGRGRILQQHWLG	FBXO15	1	Q8NCQ5
NLMILCWGEGHGSSI	CDO1	71	Q16878
SHVMVRVGGGWDTLE	GAS2L1	251	Q99501
GKHVMVRVGGGWDTL	GAS2L3	256	Q86XJ1
QPWGGTHRIMRDSGL	FSTL4	786	Q6MZW2
RKLDDGVGMLGSWHT	CDON	616	Q4KMG0
MVLIHGSGVVRAGQW	FAM172A	151	Q8WUF8
TLVGHTGGVWSSQMR	FBXW7	416	Q969H0
GVMRGAEWHSHLGSM	CPD	1151	O75976
MALGHGQARGWVASG	AKNA	161	Q7Z591
GWSALMQAARFGHVS	ANKS6	111	Q68DC2
TGQCESHWLGRLMAG	C16orf90	76	A8MZG2
VGESVSWHLFGMGNE	HEPHL1	286	Q6MZM0
RGLDMLRCIDSGHWS	SELP	361	P16109
FLHGSGDSGQGLRMW	LYPLAL1	26	Q5VWZ2
LQHVGGGQRWMLVGA	ITGA10	46	O75578
RSLSMWHGLGTQVSG	ANKS3	16	Q6ZW76
HMGGASRRVESGAWA	DENND4B	1251	O75064
TMGGGWTVLQARLDG	FGL2	246	Q14314
RIQGHTGAVTCIWMN	NSMAF	881	Q92636
LHNTSWNGMIGELIS	GRID1	496	Q9ULK0
LLGSMESESWGHRGE	KANK4	436	Q5T7N3
GHISDSMLCAGLWEG	KLK9	181	Q9UKQ9
ETGGFTMTNGAHRWS	KNDC1	1656	Q76NI1
QSNGWGVMVSHRSGE	ENO3	361	P13929
LLVQGHMEGEVWGLA	EML5	991	Q05BV3
LLVQGHMEGEVWGLA	EML6	991	Q6ZMW3
GDIHAGLNGWMEQRC	FBXO30	541	Q8TB52
GNGQIWRHMFHCTGT	CD163	641	Q86VB7
GRDSHALLWMLTLGG	DNAJC22	26	Q8N4W6
VWGHCTKMATRGSNG	DKK3	191	Q9UBP4
MQASGVRWCVVHGRL	DPPA2	216	Q7Z7J5
RHGGRTVENMSIIGW	AGPAT2	51	O15120
LGGFVSHMDCWRVNG	PPM1F	306	P49593
TLMGNGSIICAVHWD	OR11G2	76	Q8NGC1
LCNGHTTGMDVLWAG	OGT	926	O15294
CTVLVAGAWVAGSMH	OR10G2	146	Q8NGC3
GVDRCASWNGSMHNG	MN1	466	Q10571
GAWVLEGASHPGVRM	TESMIN	141	Q9Y4I5
LGSGVHGGVDWMRKL	EYA2	366	O00167
VSQLTWARHGESGSM	PVR	61	P15151
GVGDRPVVWISHSMG	SERAC1	486	Q96JX3
RPGWHIECSAMAGTL	CARS1	341	P49589
WVFGGGTTAMLSCLH	SLC9A6	491	Q92581
GLGHWALAQSGMVQL	SYNE4	126	Q8N205
NWSCDDLMGGGGLHS	GFOD1	161	Q9NXC2
GMGHASVERILDTWQ	NIN	301	Q8N4C6
VMHLSGGWGKILHEQ	RGS22	931	Q8NE09
LMNSGTSHDWRLRCG	TAF2	956	Q6P1X5
CMVWRLLHQGGLSVG	NBEAL2	2526	Q6ZNJ1
MCKGDTVAWHLLGLG	HEPH	636	Q9BQS7
RMWGHLSEGYGQLCS	HIP1	126	O00291
LTNWHAGNIEVGHGM	SMYD1	401	Q8NB12
KGMWSEGNGSHTIRD	SND1	161	Q7KZF4
HRWAAGLMSGVVEAV	SLC25A53	116	Q5H9E4
WMGAHGAGVLLSQDC	IL9R	326	Q01113
SAHGLESDVWSLGCM	PLK4	186	O00444
VCSHMGGKAWGSRVV	AARS2	946	Q5JTZ9
CGLGGMRHNSVVLGW	SLC12A4	781	Q9UP95
GHQGGTDITWMVLLG	SLC39A5	376	Q6ZMH5
WNHVSMCILNGGGIR	NT5E	381	P21589
MSLSTHSSVQAGGWR	APC	2491	P25054
DNHGLVWLSAAMGFG	CLEC18B	401	Q6UXF7
SALCWGTGGETQMLV	WDR74	46	Q6RFH5
TLCWAIGSISGAMHE	XPO1	496	O14980
HGRTMVVAWGTGQVG	WDR90	476	Q96KV7
HSVIMWDIGGRKGTA	WDFY2	221	Q96P53
SVMAGGTLTGWHADV	RALGAPA1	1046	Q6GYQ0
GLGWEVNLTNHCGFM	RALGAPA1	1841	Q6GYQ0
LVAHVWGNLMGTSAL	RBP3	151	P10745
LLVLHTVWNGNGMIG	RHCE	346	P18577
TRMHWSNVGGLSGMI	ELAC2	111	Q9BQ52
RCRGRLEVMHGGSWG	SSC4D	66	Q8WTU2
LEVMHGGSWGSVCDD	SSC4D	71	Q8WTU2
TGAWIITGGSHTGVM	TRPM2	201	O94759
SQGLRGCGVGQMDWT	TNKS1BP1	1331	Q9C0C2
DGSHWLSMLGAIQQL	UGT1A1	36	P22309
GGQECTGLVEQHSWM	ZNF395	86	Q9H8N7
WFTAMLHCFGGGILS	TMEM38B	51	Q9NVV0
ASTLIVGHWDGNMSL	WDR76	416	Q9H967
SGSFMLQLTCRWDGG	VSIG10	236	Q8N0Z9
GELWLSRGEHRMGIQ	TOMM20L	81	Q6UXN7
NHLSLQVWLMGGFIG	TM4SF5	41	O14894
VGGNTARLVAMGSAW	GTF3C1	1796	Q12789
TVDMGGHIRLWETGL	VWA8	1501	A3KMH1
WMVSVRANGTHICAG	PRSS50	126	Q9UI38
AENAIVHMGGQWLGG	TIAL1	151	Q01085
QLWRMTGTGMLAHEG	VPS13D	3646	Q5THJ4
LSEGSHGNLTAMWGC	KIAA1958	36	Q8N8K9
HCGSLLWGIMRQGLQ	PRKCH	261	P24723